Floatz logo

PREDNISONE TABLETS

Duchenne Muscular Dystrophy

University of FloridaSmall moleculePhase 3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
81/ 100

Competitive context

56 Active assets in the Duchenne Muscular Dystrophy cohort.

Asset / SponsorPhaseRating
Viltolarsen
NS Pharma, Inc.
Phase 4BBB
Golodirsen
Rare Disease Research, LLC
Phase 4BB
Aoc 1044
Avidity Biosciences, Inc.
Phase 3BB
Delandistrogene Moxeparvovec
Sarepta Therapeutics, Inc.
Phase 3BB
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Anne M. Connolly
Phase 4BB

View all 50 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →